Solid-Phase Synthesis of Glycopeptide 9
Glycopeptide 9 was prepared according to our previously reported method (Wu, Z. M.; Guo, X. Q.; Guo, Z. W., Chem Commun 2010, 46, 5773-5774) . After the glycopeptide assembly on the resin was finished, the N-terminal Fmoc was removed by 10% of piperidine. Then, the resin was treated with 95% aq. TFA containing 2.5% Et 3 SiH at rt for 2 h to release acetylated glycopeptide 13, which was characterized with MALDI-TOF MS [ Figure 5, 
SrtA-catalyzed reactions of different concentrations of 1
The reaction was performed in 100 μL solution with a fixed concentration of SrtA (40 μM) and different concentrations of 1 (0.1, 0.25, 0.5, 1, 2.5, 5, and 10 mM). Reactions were carried out in 0.3 M Tris-HCl buffer (pH = 7.5) containing 0.15 M NaCl, 5 mM CaCl 2 , and 2 mM 2-mercaptoethanol.
After the reaction was incubated at 37 o C for 20 h, 20 μL of the reaction mixture was taken and then quenched with the same volume of 0.1% of TFA. The aliquots were analyzed by HPLC using a RP C18 column (Figure 8) , and the fractions were analyzed by MALDI-TOF MS (Figures 11-14) . The reactions were performed in 100 μL solutions with a fixed concentration of SrtA (40 μM) and 0.5 mM of peptide 6, 7 or 8 in 0.3 M Tris-HCl buffer (pH = 7.5) containing 0.15 M NaCl, 5 mM CaCl 2 , and 2 mM 2-mercaptoethanol. The reaction conditions and workup procedures were identical to that used in the reactions of 1. The reaction aliquots were analyzed by HPLC with a RP C18 column (Figure 9 ), and fractions were analyzed by MALDI-TOF MS (Figures 15-24) . 
SrtA-catalyzed oligomerization and clyclization reactions of glycopeptide 9
The reaction was performed at the optimized conditions with the concentrations of 9 at 0. 
